Global Breast Cancer Screening Market Report 2019, Competitive Landscape, Trends and Opportunities
The Breast Cancer Screening market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Breast Cancer Screening market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Breast Cancer Screening market.
Major players in the global Breast Cancer Screening market include:
Gamma Medica, Inc.
Agendia BV
GE Healthcare
Hitachi Medical Corporation
Sonocine, Inc.
Quest Diagnostics Incorporated
A&G Pharmaceutical Inc.
Fujifilm Holdings Corporation
Siemens Healthcare
Aurora Imaging Technology, Inc.
Metabolomic Technologies Inc.
Myriad Genetics
Philips Healthcare
Biocrates Life Sciences AG
Dilon Technologies
Armune BioScience Inc.
Toshiba Corporation
F. Hoffmann-La Roche AG
Hologic, Inc.
On the basis of types, the Breast Cancer Screening market is primarily split into:
Physical Exam
Laboratory Tests
Imaging Tests
Genetic Tests
On the basis of applications, the market covers:
Research Labs
Cancer Institutes
Diagnostic Centers
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Breast Cancer Screening market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Breast Cancer Screening market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Breast Cancer Screening industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Breast Cancer Screening market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Breast Cancer Screening, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Breast Cancer Screening in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Breast Cancer Screening in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Breast Cancer Screening. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Breast Cancer Screening market, including the global production and revenue forecast, regional forecast. It also foresees the Breast Cancer Screening market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
The report mainly studies the size, recent trends and development status of the Breast Cancer Screening market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Breast Cancer Screening market.
Major players in the global Breast Cancer Screening market include:
Gamma Medica, Inc.
Agendia BV
GE Healthcare
Hitachi Medical Corporation
Sonocine, Inc.
Quest Diagnostics Incorporated
A&G Pharmaceutical Inc.
Fujifilm Holdings Corporation
Siemens Healthcare
Aurora Imaging Technology, Inc.
Metabolomic Technologies Inc.
Myriad Genetics
Philips Healthcare
Biocrates Life Sciences AG
Dilon Technologies
Armune BioScience Inc.
Toshiba Corporation
F. Hoffmann-La Roche AG
Hologic, Inc.
On the basis of types, the Breast Cancer Screening market is primarily split into:
Physical Exam
Laboratory Tests
Imaging Tests
Genetic Tests
On the basis of applications, the market covers:
Research Labs
Cancer Institutes
Diagnostic Centers
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Breast Cancer Screening market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Breast Cancer Screening market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Breast Cancer Screening industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Breast Cancer Screening market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Breast Cancer Screening, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Breast Cancer Screening in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Breast Cancer Screening in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Breast Cancer Screening. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Breast Cancer Screening market, including the global production and revenue forecast, regional forecast. It also foresees the Breast Cancer Screening market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
1 BREAST CANCER SCREENING MARKET OVERVIEW
1.1 Product Overview and Scope of Breast Cancer Screening
1.2 Breast Cancer Screening Segment by Type
1.2.1 Global Breast Cancer Screening Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Physical Exam
1.2.3 The Market Profile of Laboratory Tests
1.2.4 The Market Profile of Imaging Tests
1.2.5 The Market Profile of Genetic Tests
1.3 Global Breast Cancer Screening Segment by Application
1.3.1 Breast Cancer Screening Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Research Labs
1.3.3 The Market Profile of Cancer Institutes
1.3.4 The Market Profile of Diagnostic Centers
1.3.5 The Market Profile of Others
1.4 Global Breast Cancer Screening Market by Region (2014-2026)
1.4.1 Global Breast Cancer Screening Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.3 Europe Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.3.1 Germany Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.3.2 UK Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.3.3 France Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.3.4 Italy Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.3.5 Spain Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.3.6 Russia Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.3.7 Poland Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.4 China Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.5 Japan Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.6 India Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.8 Central and South America Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Breast Cancer Screening Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Breast Cancer Screening (2014-2026)
1.5.1 Global Breast Cancer Screening Revenue Status and Outlook (2014-2026)
1.5.2 Global Breast Cancer Screening Production Status and Outlook (2014-2026)
2 GLOBAL BREAST CANCER SCREENING MARKET LANDSCAPE BY PLAYER
2.1 Global Breast Cancer Screening Production and Share by Player (2014-2019)
2.2 Global Breast Cancer Screening Revenue and Market Share by Player (2014-2019)
2.3 Global Breast Cancer Screening Average Price by Player (2014-2019)
2.4 Breast Cancer Screening Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Breast Cancer Screening Market Competitive Situation and Trends
2.5.1 Breast Cancer Screening Market Concentration Rate
2.5.2 Breast Cancer Screening Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Gamma Medica, Inc.
3.1.1 Gamma Medica, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Breast Cancer Screening Product Profiles, Application and Specification
3.1.3 Gamma Medica, Inc. Breast Cancer Screening Market Performance (2014-2019)
3.1.4 Gamma Medica, Inc. Business Overview
3.2 Agendia BV
3.2.1 Agendia BV Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Breast Cancer Screening Product Profiles, Application and Specification
3.2.3 Agendia BV Breast Cancer Screening Market Performance (2014-2019)
3.2.4 Agendia BV Business Overview
3.3 GE Healthcare
3.3.1 GE Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Breast Cancer Screening Product Profiles, Application and Specification
3.3.3 GE Healthcare Breast Cancer Screening Market Performance (2014-2019)
3.3.4 GE Healthcare Business Overview
3.4 Hitachi Medical Corporation
3.4.1 Hitachi Medical Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Breast Cancer Screening Product Profiles, Application and Specification
3.4.3 Hitachi Medical Corporation Breast Cancer Screening Market Performance (2014-2019)
3.4.4 Hitachi Medical Corporation Business Overview
3.5 Sonocine, Inc.
3.5.1 Sonocine, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Breast Cancer Screening Product Profiles, Application and Specification
3.5.3 Sonocine, Inc. Breast Cancer Screening Market Performance (2014-2019)
3.5.4 Sonocine, Inc. Business Overview
3.6 Quest Diagnostics Incorporated
3.6.1 Quest Diagnostics Incorporated Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Breast Cancer Screening Product Profiles, Application and Specification
3.6.3 Quest Diagnostics Incorporated Breast Cancer Screening Market Performance (2014-2019)
3.6.4 Quest Diagnostics Incorporated Business Overview
3.7 A&G Pharmaceutical Inc.
3.7.1 A&G Pharmaceutical Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Breast Cancer Screening Product Profiles, Application and Specification
3.7.3 A&G Pharmaceutical Inc. Breast Cancer Screening Market Performance (2014-2019)
3.7.4 A&G Pharmaceutical Inc. Business Overview
3.8 Fujifilm Holdings Corporation
3.8.1 Fujifilm Holdings Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Breast Cancer Screening Product Profiles, Application and Specification
3.8.3 Fujifilm Holdings Corporation Breast Cancer Screening Market Performance (2014-2019)
3.8.4 Fujifilm Holdings Corporation Business Overview
3.9 Siemens Healthcare
3.9.1 Siemens Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Breast Cancer Screening Product Profiles, Application and Specification
3.9.3 Siemens Healthcare Breast Cancer Screening Market Performance (2014-2019)
3.9.4 Siemens Healthcare Business Overview
3.10 Aurora Imaging Technology, Inc.
3.10.1 Aurora Imaging Technology, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Breast Cancer Screening Product Profiles, Application and Specification
3.10.3 Aurora Imaging Technology, Inc. Breast Cancer Screening Market Performance (2014-2019)
3.10.4 Aurora Imaging Technology, Inc. Business Overview
3.11 Metabolomic Technologies Inc.
3.11.1 Metabolomic Technologies Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Breast Cancer Screening Product Profiles, Application and Specification
3.11.3 Metabolomic Technologies Inc. Breast Cancer Screening Market Performance (2014-2019)
3.11.4 Metabolomic Technologies Inc. Business Overview
3.12 Myriad Genetics
3.12.1 Myriad Genetics Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Breast Cancer Screening Product Profiles, Application and Specification
3.12.3 Myriad Genetics Breast Cancer Screening Market Performance (2014-2019)
3.12.4 Myriad Genetics Business Overview
3.13 Philips Healthcare
3.13.1 Philips Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Breast Cancer Screening Product Profiles, Application and Specification
3.13.3 Philips Healthcare Breast Cancer Screening Market Performance (2014-2019)
3.13.4 Philips Healthcare Business Overview
3.14 Biocrates Life Sciences AG
3.14.1 Biocrates Life Sciences AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Breast Cancer Screening Product Profiles, Application and Specification
3.14.3 Biocrates Life Sciences AG Breast Cancer Screening Market Performance (2014-2019)
3.14.4 Biocrates Life Sciences AG Business Overview
3.15 Dilon Technologies
3.15.1 Dilon Technologies Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Breast Cancer Screening Product Profiles, Application and Specification
3.15.3 Dilon Technologies Breast Cancer Screening Market Performance (2014-2019)
3.15.4 Dilon Technologies Business Overview
3.16 Armune BioScience Inc.
3.16.1 Armune BioScience Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Breast Cancer Screening Product Profiles, Application and Specification
3.16.3 Armune BioScience Inc. Breast Cancer Screening Market Performance (2014-2019)
3.16.4 Armune BioScience Inc. Business Overview
3.17 Toshiba Corporation
3.17.1 Toshiba Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Breast Cancer Screening Product Profiles, Application and Specification
3.17.3 Toshiba Corporation Breast Cancer Screening Market Performance (2014-2019)
3.17.4 Toshiba Corporation Business Overview
3.18 F. Hoffmann-La Roche AG
3.18.1 F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Breast Cancer Screening Product Profiles, Application and Specification
3.18.3 F. Hoffmann-La Roche AG Breast Cancer Screening Market Performance (2014-2019)
3.18.4 F. Hoffmann-La Roche AG Business Overview
3.19 Hologic, Inc.
3.19.1 Hologic, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Breast Cancer Screening Product Profiles, Application and Specification
3.19.3 Hologic, Inc. Breast Cancer Screening Market Performance (2014-2019)
3.19.4 Hologic, Inc. Business Overview
4 GLOBAL BREAST CANCER SCREENING PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Breast Cancer Screening Production and Market Share by Type (2014-2019)
4.2 Global Breast Cancer Screening Revenue and Market Share by Type (2014-2019)
4.3 Global Breast Cancer Screening Price by Type (2014-2019)
4.4 Global Breast Cancer Screening Production Growth Rate by Type (2014-2019)
4.4.1 Global Breast Cancer Screening Production Growth Rate of Physical Exam (2014-2019)
4.4.2 Global Breast Cancer Screening Production Growth Rate of Laboratory Tests (2014-2019)
4.4.3 Global Breast Cancer Screening Production Growth Rate of Imaging Tests (2014-2019)
4.4.4 Global Breast Cancer Screening Production Growth Rate of Genetic Tests (2014-2019)
5 GLOBAL BREAST CANCER SCREENING MARKET ANALYSIS BY APPLICATION
5.1 Global Breast Cancer Screening Consumption and Market Share by Application (2014-2019)
5.2 Global Breast Cancer Screening Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Breast Cancer Screening Consumption Growth Rate of Research Labs (2014-2019)
5.2.2 Global Breast Cancer Screening Consumption Growth Rate of Cancer Institutes (2014-2019)
5.2.3 Global Breast Cancer Screening Consumption Growth Rate of Diagnostic Centers (2014-2019)
5.2.4 Global Breast Cancer Screening Consumption Growth Rate of Others (2014-2019)
6 GLOBAL BREAST CANCER SCREENING PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Breast Cancer Screening Consumption by Region (2014-2019)
6.2 United States Breast Cancer Screening Production, Consumption, Export, Import (2014-2019)
6.3 Europe Breast Cancer Screening Production, Consumption, Export, Import (2014-2019)
6.4 China Breast Cancer Screening Production, Consumption, Export, Import (2014-2019)
6.5 Japan Breast Cancer Screening Production, Consumption, Export, Import (2014-2019)
6.6 India Breast Cancer Screening Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Breast Cancer Screening Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Breast Cancer Screening Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Breast Cancer Screening Production, Consumption, Export, Import (2014-2019)
7 GLOBAL BREAST CANCER SCREENING PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Breast Cancer Screening Production and Market Share by Region (2014-2019)
7.2 Global Breast Cancer Screening Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
8 BREAST CANCER SCREENING MANUFACTURING ANALYSIS
8.1 Breast Cancer Screening Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Breast Cancer Screening
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Breast Cancer Screening Industrial Chain Analysis
9.2 Raw Materials Sources of Breast Cancer Screening Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Breast Cancer Screening
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL BREAST CANCER SCREENING MARKET FORECAST (2019-2026)
11.1 Global Breast Cancer Screening Production, Revenue Forecast (2019-2026)
11.1.1 Global Breast Cancer Screening Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Breast Cancer Screening Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Breast Cancer Screening Price and Trend Forecast (2019-2026)
11.2 Global Breast Cancer Screening Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Breast Cancer Screening Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Breast Cancer Screening Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Breast Cancer Screening Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Breast Cancer Screening Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Breast Cancer Screening Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Breast Cancer Screening Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Breast Cancer Screening Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Breast Cancer Screening Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Breast Cancer Screening Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Breast Cancer Screening Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Breast Cancer Screening
1.2 Breast Cancer Screening Segment by Type
1.2.1 Global Breast Cancer Screening Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Physical Exam
1.2.3 The Market Profile of Laboratory Tests
1.2.4 The Market Profile of Imaging Tests
1.2.5 The Market Profile of Genetic Tests
1.3 Global Breast Cancer Screening Segment by Application
1.3.1 Breast Cancer Screening Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Research Labs
1.3.3 The Market Profile of Cancer Institutes
1.3.4 The Market Profile of Diagnostic Centers
1.3.5 The Market Profile of Others
1.4 Global Breast Cancer Screening Market by Region (2014-2026)
1.4.1 Global Breast Cancer Screening Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.3 Europe Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.3.1 Germany Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.3.2 UK Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.3.3 France Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.3.4 Italy Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.3.5 Spain Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.3.6 Russia Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.3.7 Poland Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.4 China Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.5 Japan Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.6 India Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.8 Central and South America Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Breast Cancer Screening Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Breast Cancer Screening Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Breast Cancer Screening (2014-2026)
1.5.1 Global Breast Cancer Screening Revenue Status and Outlook (2014-2026)
1.5.2 Global Breast Cancer Screening Production Status and Outlook (2014-2026)
2 GLOBAL BREAST CANCER SCREENING MARKET LANDSCAPE BY PLAYER
2.1 Global Breast Cancer Screening Production and Share by Player (2014-2019)
2.2 Global Breast Cancer Screening Revenue and Market Share by Player (2014-2019)
2.3 Global Breast Cancer Screening Average Price by Player (2014-2019)
2.4 Breast Cancer Screening Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Breast Cancer Screening Market Competitive Situation and Trends
2.5.1 Breast Cancer Screening Market Concentration Rate
2.5.2 Breast Cancer Screening Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Gamma Medica, Inc.
3.1.1 Gamma Medica, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Breast Cancer Screening Product Profiles, Application and Specification
3.1.3 Gamma Medica, Inc. Breast Cancer Screening Market Performance (2014-2019)
3.1.4 Gamma Medica, Inc. Business Overview
3.2 Agendia BV
3.2.1 Agendia BV Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Breast Cancer Screening Product Profiles, Application and Specification
3.2.3 Agendia BV Breast Cancer Screening Market Performance (2014-2019)
3.2.4 Agendia BV Business Overview
3.3 GE Healthcare
3.3.1 GE Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Breast Cancer Screening Product Profiles, Application and Specification
3.3.3 GE Healthcare Breast Cancer Screening Market Performance (2014-2019)
3.3.4 GE Healthcare Business Overview
3.4 Hitachi Medical Corporation
3.4.1 Hitachi Medical Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Breast Cancer Screening Product Profiles, Application and Specification
3.4.3 Hitachi Medical Corporation Breast Cancer Screening Market Performance (2014-2019)
3.4.4 Hitachi Medical Corporation Business Overview
3.5 Sonocine, Inc.
3.5.1 Sonocine, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Breast Cancer Screening Product Profiles, Application and Specification
3.5.3 Sonocine, Inc. Breast Cancer Screening Market Performance (2014-2019)
3.5.4 Sonocine, Inc. Business Overview
3.6 Quest Diagnostics Incorporated
3.6.1 Quest Diagnostics Incorporated Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Breast Cancer Screening Product Profiles, Application and Specification
3.6.3 Quest Diagnostics Incorporated Breast Cancer Screening Market Performance (2014-2019)
3.6.4 Quest Diagnostics Incorporated Business Overview
3.7 A&G Pharmaceutical Inc.
3.7.1 A&G Pharmaceutical Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Breast Cancer Screening Product Profiles, Application and Specification
3.7.3 A&G Pharmaceutical Inc. Breast Cancer Screening Market Performance (2014-2019)
3.7.4 A&G Pharmaceutical Inc. Business Overview
3.8 Fujifilm Holdings Corporation
3.8.1 Fujifilm Holdings Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Breast Cancer Screening Product Profiles, Application and Specification
3.8.3 Fujifilm Holdings Corporation Breast Cancer Screening Market Performance (2014-2019)
3.8.4 Fujifilm Holdings Corporation Business Overview
3.9 Siemens Healthcare
3.9.1 Siemens Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Breast Cancer Screening Product Profiles, Application and Specification
3.9.3 Siemens Healthcare Breast Cancer Screening Market Performance (2014-2019)
3.9.4 Siemens Healthcare Business Overview
3.10 Aurora Imaging Technology, Inc.
3.10.1 Aurora Imaging Technology, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Breast Cancer Screening Product Profiles, Application and Specification
3.10.3 Aurora Imaging Technology, Inc. Breast Cancer Screening Market Performance (2014-2019)
3.10.4 Aurora Imaging Technology, Inc. Business Overview
3.11 Metabolomic Technologies Inc.
3.11.1 Metabolomic Technologies Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Breast Cancer Screening Product Profiles, Application and Specification
3.11.3 Metabolomic Technologies Inc. Breast Cancer Screening Market Performance (2014-2019)
3.11.4 Metabolomic Technologies Inc. Business Overview
3.12 Myriad Genetics
3.12.1 Myriad Genetics Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Breast Cancer Screening Product Profiles, Application and Specification
3.12.3 Myriad Genetics Breast Cancer Screening Market Performance (2014-2019)
3.12.4 Myriad Genetics Business Overview
3.13 Philips Healthcare
3.13.1 Philips Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Breast Cancer Screening Product Profiles, Application and Specification
3.13.3 Philips Healthcare Breast Cancer Screening Market Performance (2014-2019)
3.13.4 Philips Healthcare Business Overview
3.14 Biocrates Life Sciences AG
3.14.1 Biocrates Life Sciences AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Breast Cancer Screening Product Profiles, Application and Specification
3.14.3 Biocrates Life Sciences AG Breast Cancer Screening Market Performance (2014-2019)
3.14.4 Biocrates Life Sciences AG Business Overview
3.15 Dilon Technologies
3.15.1 Dilon Technologies Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Breast Cancer Screening Product Profiles, Application and Specification
3.15.3 Dilon Technologies Breast Cancer Screening Market Performance (2014-2019)
3.15.4 Dilon Technologies Business Overview
3.16 Armune BioScience Inc.
3.16.1 Armune BioScience Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Breast Cancer Screening Product Profiles, Application and Specification
3.16.3 Armune BioScience Inc. Breast Cancer Screening Market Performance (2014-2019)
3.16.4 Armune BioScience Inc. Business Overview
3.17 Toshiba Corporation
3.17.1 Toshiba Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Breast Cancer Screening Product Profiles, Application and Specification
3.17.3 Toshiba Corporation Breast Cancer Screening Market Performance (2014-2019)
3.17.4 Toshiba Corporation Business Overview
3.18 F. Hoffmann-La Roche AG
3.18.1 F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Breast Cancer Screening Product Profiles, Application and Specification
3.18.3 F. Hoffmann-La Roche AG Breast Cancer Screening Market Performance (2014-2019)
3.18.4 F. Hoffmann-La Roche AG Business Overview
3.19 Hologic, Inc.
3.19.1 Hologic, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Breast Cancer Screening Product Profiles, Application and Specification
3.19.3 Hologic, Inc. Breast Cancer Screening Market Performance (2014-2019)
3.19.4 Hologic, Inc. Business Overview
4 GLOBAL BREAST CANCER SCREENING PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Breast Cancer Screening Production and Market Share by Type (2014-2019)
4.2 Global Breast Cancer Screening Revenue and Market Share by Type (2014-2019)
4.3 Global Breast Cancer Screening Price by Type (2014-2019)
4.4 Global Breast Cancer Screening Production Growth Rate by Type (2014-2019)
4.4.1 Global Breast Cancer Screening Production Growth Rate of Physical Exam (2014-2019)
4.4.2 Global Breast Cancer Screening Production Growth Rate of Laboratory Tests (2014-2019)
4.4.3 Global Breast Cancer Screening Production Growth Rate of Imaging Tests (2014-2019)
4.4.4 Global Breast Cancer Screening Production Growth Rate of Genetic Tests (2014-2019)
5 GLOBAL BREAST CANCER SCREENING MARKET ANALYSIS BY APPLICATION
5.1 Global Breast Cancer Screening Consumption and Market Share by Application (2014-2019)
5.2 Global Breast Cancer Screening Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Breast Cancer Screening Consumption Growth Rate of Research Labs (2014-2019)
5.2.2 Global Breast Cancer Screening Consumption Growth Rate of Cancer Institutes (2014-2019)
5.2.3 Global Breast Cancer Screening Consumption Growth Rate of Diagnostic Centers (2014-2019)
5.2.4 Global Breast Cancer Screening Consumption Growth Rate of Others (2014-2019)
6 GLOBAL BREAST CANCER SCREENING PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Breast Cancer Screening Consumption by Region (2014-2019)
6.2 United States Breast Cancer Screening Production, Consumption, Export, Import (2014-2019)
6.3 Europe Breast Cancer Screening Production, Consumption, Export, Import (2014-2019)
6.4 China Breast Cancer Screening Production, Consumption, Export, Import (2014-2019)
6.5 Japan Breast Cancer Screening Production, Consumption, Export, Import (2014-2019)
6.6 India Breast Cancer Screening Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Breast Cancer Screening Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Breast Cancer Screening Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Breast Cancer Screening Production, Consumption, Export, Import (2014-2019)
7 GLOBAL BREAST CANCER SCREENING PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Breast Cancer Screening Production and Market Share by Region (2014-2019)
7.2 Global Breast Cancer Screening Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Breast Cancer Screening Production, Revenue, Price and Gross Margin (2014-2019)
8 BREAST CANCER SCREENING MANUFACTURING ANALYSIS
8.1 Breast Cancer Screening Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Breast Cancer Screening
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Breast Cancer Screening Industrial Chain Analysis
9.2 Raw Materials Sources of Breast Cancer Screening Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Breast Cancer Screening
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL BREAST CANCER SCREENING MARKET FORECAST (2019-2026)
11.1 Global Breast Cancer Screening Production, Revenue Forecast (2019-2026)
11.1.1 Global Breast Cancer Screening Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Breast Cancer Screening Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Breast Cancer Screening Price and Trend Forecast (2019-2026)
11.2 Global Breast Cancer Screening Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Breast Cancer Screening Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Breast Cancer Screening Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Breast Cancer Screening Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Breast Cancer Screening Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Breast Cancer Screening Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Breast Cancer Screening Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Breast Cancer Screening Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Breast Cancer Screening Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Breast Cancer Screening Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Breast Cancer Screening Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
